Clinical Trials

Drug Development Drug Efficacy Research Studies Phase 3 Trials Randomized Controlled Trials Cancer Research Phase 1 Trials Experimental Treatments Animal Studies Research Methodology

Psilocybin Prevents Chemotherapy Nerve Damage in Mice

The result reveals a 5‑HT2A serotonin mechanism that preserves mitochondrial trafficking, prompting planned human trials.

Semaglutide Extends Lifespan and Slows Ageing in Older Female Mice

Alumis Shares Plunge After Phase 2b Lupus Trial Misses Primary Goal

Novartis Moves to File Oral MS Drug After Phase‑3 Win as Separate CAR‑T Trials Are Paused

Pacibekitug Cuts hs-CRP by Up to 89% in Phase II Kidney Disease Trial

Small Trial Finds Keto Cuts Liver Fat and Reverses Prediabetes More Than Other Diets

Moderna and Merck Report Positive Phase 3 Result for Personalized mRNA Melanoma Vaccine

Nano‑ERASER Converts Astrocytes to Neurons and Restores Memory in Mice

Upadacitinib Produces Major Hair Regrowth in Severe Alopecia in Phase 3 Trials

Hanmi Licenses HM17321 to Genentech in $190 Million Upfront Deal Valued at $2.3 Billion

Urolithin A Turns On Heart Relaxation Switch and Reverses Lab Signs of HFpEF

Oral Fecal Microbiome Capsules Raise Peanut Tolerance in Small Phase I Trial

Study Suggests Viagra Ingredient May Slow Cancer Spread

Oral Antiviral Candidate Stops Measles-Like Virus Transmission in Ferret Study

11-Year-Old Becomes First UK Patient to Receive BBS10 Gene Therapy

Geroscience Advances From Lab to First Human Trials

Patient-Specific Artery 'Physical Twins' Reveal Flow-Driven Stroke Risk

Lilly Will Seek FDA Approval for Retatrutide in Q1 2027 After Two More Positive Phase 3 Trials

DRC Bundibugyo Ebola Outbreak Spurs Rush to Test Experimental Vaccines and Treatments

Double Neural Bypass Restores Movement and Touch to Paralyzed Man